EV/EBITDA
-2.19
+0.13+5.60%
68 min ago
Summary
- As of March 5, 2025, QNCX EV/EBITDA is -2.19, with a rise of +0.13 (+5.60%) during the most recent trading day.
- Over the past year, QNCX EV/EBITDA has dropped by -0.57 (-35.19%).
- QNCX EV/EBITDA is now -609.30% below its all-time high of 0.43.
Performance
QNCX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
QNCX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +5.6% | -5.5% | -6.5% |
| 1 m1 month | +5.6% | -5.5% | -6.5% |
| 3 m3 months | +30.0% | -29.8% | -33.9% |
| 6 m6 months | -84.0% | +97.8% | +94.8% |
| ytdytd | +25.0% | -24.8% | -28.5% |
| 1 y1 year | -35.2% | +71.8% | +19.8% |
| 5 y5 years | +93.5% | -94.3% | -97.0% |
QNCX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -4.8% | -2.53 | +13.4% | |
| 3 m | 3-month | -2.09 | -4.8% | -3.23 | +32.2% |
| 6 m | 6-month | -1.12 | -95.5% | -3.23 | +32.2% |
| 1 y | 1-year | -0.75 | -192.0% | -3.23 | +32.2% |
| 3 y | 3-year | 0.43 | -609.3% | -3.23 | +32.2% |
| 5 y | 5-year | 0.43 | -609.3% | -39.94 | +94.5% |
| alltime | all time | 0.43 | -609.3% | -75.99 | +97.1% |
Quince Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -2.19(-25.0%) |
| 2024 | -2.92(+111.6%) |
| 2023 | -1.38(-420.9%) |
| Date | Value |
|---|---|
| 2022 | 0.43(-112.4%) |
| 2021 | -3.46(-64.0%) |
| 2020 | -9.60(-74.3%) |
| 2019 | -37.38 |
FAQ
- What is Quince Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Quince Therapeutics?
- What is QNCX EV/EBITDA year-to-date change?
- What is Quince Therapeutics EV/EBITDA year-on-year change?
What is Quince Therapeutics EV/EBITDA?
The current EV/EBITDA of QNCX is -2.19
What is the all time high EV/EBITDA for Quince Therapeutics?
Quince Therapeutics all-time high EV/EBITDA is 0.43
What is QNCX EV/EBITDA year-to-date change?
Quince Therapeutics EV/EBITDA has changed by +0.73 (+25.00%) since the beginning of the year
What is Quince Therapeutics EV/EBITDA year-on-year change?
Over the past year, QNCX EV/EBITDA has changed by -0.57 (-35.19%)